Contract 75A50120C00114
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · September 30, 2020
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 30, 2020 for $125.65 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Wilmington, DE. It was awarded under full and open competition. It uses cost no fee contract pricing. If all options are exercised, the contract could reach $125.65 million.
Contract details
- PIID
- 75A50120C00114
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- R&D- Medical: Biomedical (Advanced Development)
- Place of performance
- Wilmington, DE
- First action
- September 30, 2020
Description
THIRD NO-COST EXTENSION FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING
Modification timeline
-
September 30, 2020Mod P00006 · Other Administrative Action$125.65M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00114?
Contract 75A50120C00114 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on September 30, 2020 for $125.65 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50120C00114?
Astrazeneca Pharmaceuticals Lp won contract 75A50120C00114 from Department Of Health And Human Services.
How much is contract 75A50120C00114 worth?
Contract 75A50120C00114 has obligated $0 to date but carries a potential ceiling of $125.65 million if fully funded and all options are exercised.